In relation to the tender offer by TCG2509 Co., Ltd. for Hogi Medical Co., Ltd., the number of shares owned by GMO was corrected from 2,237,900 shares (10.38%) to 2,256,100 shares (10.46%), and on January 6, 2026, an amendment to the subscription agreement was executed.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"3593","jir_company_name":"Hogi Medical Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-01-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/01\/3593-20260106-02.pdf","jir_short_summary":"In relation to the tender offer by TCG2509 Co., Ltd. for Hogi Medical Co., Ltd., the number of shares owned by GMO was corrected from 2,237,900 shares (10.38%) to 2,256,100 shares (10.46%), and on January 6, 2026, an amendment to the subscription agreement was executed.","jir_summary":"### Overview of Tender Offer and Corrections\nTCG2509 Co., Ltd. commenced a tender offer for common shares of Hogi Medical Co., Ltd. on December 18, 2025. The tender offerors initially recognized that the number of shares held by Gransham, Mayo, and Van Otterloo & Company LLC (GMO) was 2,237,900 shares (10.38%). However, on December 26, 2025, it was revealed that the actual number was 2,256,100 shares (10.46%), which is 18,200 shares more. Accordingly, on January 6, 2026, an amendment to the subscription agreement with GMO was executed, and the descriptions in the tender offer notification and public announcement of the tender offer commencement were corrected.\n\n### Impact on Shareholders and Future Outlook\nThe lower limit of the scheduled purchase quantity is set at 14,362,400 shares (66.62%), and if the total number of tendered shares does not reach this threshold, the purchase will not proceed. Even after the correction of the number of shares owned by GMO, the lower limit of the scheduled purchase quantity approximately maintains the level of a majority of minority shareholders. The tender offerors judge that the amendment to the subscription agreement with GMO does not impair the rationality, fairness, or appropriateness of this transaction. Going forward, this tender offer will continue to be properly conducted in accordance with Japan\u2019s Financial Instruments and Exchange Act.","jir_financial_highlights":"Number of Shares Owned by GMO: 2,256,100 shares (Increase of 18,200 shares from 2,237,900 shares before correction)\nOwnership Ratio of GMO: 10.46% (Increase of 0.08% from 10.38% before correction)\nLower Limit of Scheduled Purchase Quantity: 14,362,400 shares (66.62%) (Unknown (No change))","jir_category":"","jir_hashtags":"#HogiMedicalCoLtd, #TenderOffer, #TSEPrime","jir_key_figures":"Number of Shares Owned by GMO: 2,256,100 shares (post-correction)\nOwnership Ratio of GMO: 10.46% (post-correction)\nLower Limit of Scheduled Purchase Quantity: 14,362,400 shares (66.62%)","jir_meta_title":"Correction of GMO Share Ownership and Subscription Agreement Amendment Regarding Tender Offer for Hogi Medical Co., Ltd. (2,256,100 shares \/ 10.46%)","jir_meta_description":"In the tender offer by TCG2509 Co., Ltd. for Hogi Medical Co., Ltd., the number of shares owned by GMO was corrected from 2,237,900 shares to 2,256,100 shares, and an amendment to the subscription agreement was executed on January 6, 2026.","jir_og_title":"Important Correction Notice Regarding Tender Offer for Hogi Medical Co., Ltd.","jir_og_description":"TCG2509 Co., Ltd. announced a correction to the number of shares owned by GMO and an amendment to the subscription agreement in relation to the tender offer for Hogi Medical Co., Ltd.","jir_og_image_url":"\/assets\/og\/company-tender_offer.jpg","jir_chart_data_collection":"[]","ir_related_company":9238,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"tender_offer","footnotes":""},"sector":[],"importance":[],"class_list":["post-14475","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n